Navigation Links
World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial
Date:7/23/2009

Infusion Procedure Performed on July 17th

LOUISVILLE, Ky., July 23 /PRNewswire-USNewswire/ -- University of Louisville physicians performed the world's first cardiac adult stem cell infusion procedure at Jewish Hospital in Louisville, KY, on July 17, 2009. The procedure is part of the first FDA-approved clinical trial using adult cardiac stem cells to treat heart disease.

The first patient, along with clinical study leader Roberto Bolli, Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology and Director of UofL's Institute for Molecular Cardiology, and Mark Slaughter, M.D., Chief of the Division of Cardiothoracic Surgery at UofL and Director of the Heart Transplant and Mechanical Assist Device Program at Jewish Hospital, will speak at a news briefing on Friday, July 24 at 9:30 a.m. (EDT). The location is the Jewish Hospital Heart & Lung Center, Hank Wagner Conference Center (CC) located at 201 Abraham Flexner Way in Louisville, KY.

The news briefing along with b-roll will be uplinked via satellite from 12-1 p.m. (EDT) the same day at the following coordinates:

C-band AMC 6 Transponder 21

Uplink Frequency 6345 Horizontal

Downlink Frequency 4120 Vertical

B-roll and photography will also be provided at the news briefing.


'/>"/>
SOURCE Jewish Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor.
2. Variants of umami taste receptor contribute to our individualized flavor worlds
3. Scienceroll.com on the Medical Implications of Virtual Worlds
4. Gunther Von Hagens BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
5. BODY WORLDS Exhibition Uses Lung Specimens to Launch Anti-Smoking Campaign at the San Diego Natural History Museum
6. HHS AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008
7. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
8. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
9. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
10. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
11. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: